Antihistamine for use in treatment of breast cancer

Disclosed herein is desloratadine or ebastin for use in treatment of a patient diagnosed with breast cancer. Also disclosed is desloratadine or ebastin for use in treatment of a patient diagnosed with a cancer type susceptible to immunotherapy. 本文公开的是地氯雷他定或依巴斯汀用于治疗诊断患有乳腺癌的患者。还公开的是地氯雷他定或依巴斯汀用于治疗诊断患有对...

Full description

Saved in:
Bibliographic Details
Main Authors OLSSON H KAN, EINEFORS RICKARD
Format Patent
LanguageChinese
English
Published 13.10.2017
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed herein is desloratadine or ebastin for use in treatment of a patient diagnosed with breast cancer. Also disclosed is desloratadine or ebastin for use in treatment of a patient diagnosed with a cancer type susceptible to immunotherapy. 本文公开的是地氯雷他定或依巴斯汀用于治疗诊断患有乳腺癌的患者。还公开的是地氯雷他定或依巴斯汀用于治疗诊断患有对免疫疗法易感的癌症类型的患者。
Bibliography:Application Number: CN201680006095